TrialFind
Saved trials
Back to results
Completed
Phase 1
Biomarker Validation Following Sargramostim Treatment in Parkinson's Disease
NCT05677633
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
University of Nebraska Medical Center
Omaha, Nebraska, United States
View on ClinicalTrials.gov
Official details
Biomarker Validation Following Sargramostim Treatment in Parkinson's Disease — TrialFind